Applying precision medicine to unmet clinical needs in psoriatic disease

Nat Rev Rheumatol. 2020 Nov;16(11):609-627. doi: 10.1038/s41584-020-00507-9. Epub 2020 Oct 6.


Psoriatic disease (PsD) is a heterogeneous condition that can affect peripheral and axial joints (arthritis), entheses, skin (psoriasis) and other structures. Over the past decade, considerable advances have been made both in our understanding of the pathogenesis of PsD and in the treatment of its diverse manifestations. However, several major areas of continued unmet need in the care of patients with PsD have been identified. One of these areas is the prediction of poor outcome, notably radiographic outcome in patients with psoriatic arthritis, so that stratified medicine approaches can be taken; another is predicting response to the numerous current and emerging therapies for PsD, so that precision medicine can be applied to rapidly improve clinical outcome and reduce the risk of toxicity. In order to address these needs, novel approaches, including imaging, tissue analysis and the application of proteogenomic technologies, are proposed as methodological solutions that will assist the dissection of the critical immune-metabolic pathways in this complex disease. Learning from advances made in other inflammatory diseases, it is time to address these unmet needs in a multi-centre partnership aimed at improving short-term and long-term outcomes for patients with PsD.

Publication types

  • Review

MeSH terms

  • Arthritis, Psoriatic / diagnosis
  • Arthritis, Psoriatic / physiopathology
  • Arthritis, Psoriatic / therapy
  • Health Services Needs and Demand*
  • Humans
  • Precision Medicine*
  • Prognosis
  • Psoriasis* / diagnosis
  • Psoriasis* / physiopathology
  • Psoriasis* / therapy